Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA

Iraq war victims accuse several pharma companies of aiding and abetting a terrorist group.

Some say lyophilization has changed little in over 70 years, but a new consortium hopes to help change that.

Sitting Down With… Margaret Hamburg, President-elect AAAS, Foreign secretary of National Academy of Medicine

Can the microbiome predict the likelihood of chemotherapy side effects?

The EFPIA highlights the risks of disrupting UK–EU medicine supply chains.

How harmonization and international standards bodies bind trade and regulation in the pharma industry

Globalization has created an industrywide demand for regulatory harmonization. But who benefits?

Drugs often fail , both before and after reaching the market - but why?

Keeping close ties, locking-up loopholes, and calculating costs… What's new for pharma in business?